Works matching AU Else, Laura


Results: 53
    1

    OPTIMIZING PRE-EXPOSURE PROPHYLAXIS WITH TDF-FTC AND TAF-FTC FOR INSERTIVE SEX.

    Published in:
    Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 398
    By:
    • Herrera, Carolina;
    • Else, Laura J.;
    • Webb, Emily;
    • Pillay, Azure-Dee;
    • Seiphetlo, Thabiso B.;
    • Lebina, Limakatso;
    • Serwanga, Jennifer;
    • Ssemata, Andrew Sentoogo;
    • Namubiru, Patricia;
    • Odoch, Geoffrey;
    • Gray, Clive M.;
    • Chiodi, Francesca;
    • Khoo, Saye;
    • Martinson, Neil;
    • Fox, Julie
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.

    Published in:
    Journal of NeuroVirology, 2016, v. 22, n. 6, p. 852, doi. 10.1007/s13365-016-0448-1
    By:
    • Nightingale, Sam;
    • Geretti, Anna;
    • Beloukas, Apostolos;
    • Fisher, Martin;
    • Winston, Alan;
    • Else, Laura;
    • Nelson, Mark;
    • Taylor, Stephen;
    • Ustianowski, Andrew;
    • Ainsworth, Jonathan;
    • Gilson, Richard;
    • Haddow, Lewis;
    • Ong, Edmund;
    • Watson, Victoria;
    • Leen, Clifford;
    • Minton, Jane;
    • Post, Frank;
    • Pirmohamed, Munir;
    • Solomon, Tom;
    • Khoo, Saye
    Publication type:
    Article
    25
    26

    Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.

    Published in:
    Clinical Infectious Diseases, 2016, v. 62, n. 6, p. 675, doi. 10.1093/cid/civ1001
    By:
    • Scarsi, Kimberly K.;
    • Darin, Kristin M.;
    • Merry, Concepta;
    • Cohn, Susan E.;
    • Nakalema, Shadia;
    • Byakika-Kibwika, Pauline;
    • Buzibye, Allan;
    • Lamorde, Mohammed;
    • Back, David J.;
    • Else, Laura J.;
    • Penchala, Sujan Dilly
    Publication type:
    Article
    27
    28
    29

    Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).

    Published in:
    2019
    By:
    • Waitt, Catriona;
    • Orrell, Catherine;
    • Walimbwa, Stephen;
    • Singh, Yashna;
    • Kintu, Kenneth;
    • Simmons, Bryony;
    • Kaboggoza, Julian;
    • Sihlangu, Mary;
    • Coombs, Julie-Anne;
    • Malaba, Thoko;
    • Byamugisha, Josaphat;
    • Amara, Alieu;
    • Gini, Joshua;
    • Else, Laura;
    • Heiburg, Christie;
    • Hodel, Eva Maria;
    • Reynolds, Helen;
    • Mehta, Ushma;
    • Byakika-Kibwika, Pauline;
    • Hill, Andrew
    Publication type:
    journal article
    30
    31
    32

    Darunavir pharmacokinetics throughout pregnancy and postpartum.

    Published in:
    Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19485
    By:
    • Lambert, John;
    • Jackson, Valerie;
    • Else, Laura;
    • Lawless, Mairead;
    • McDonald, Grainne;
    • Le Blanc, Dave;
    • Patel, Anjali;
    • Stephens, Kelly;
    • Khoo, Saye
    Publication type:
    Article
    33

    The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis Open Access.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 5, p. 1455, doi. 10.1093/jac/dkaf071
    By:
    • Woolley, Stephen D;
    • Duru, Iheukwumere;
    • Pagano, Luca;
    • Lester, Rebecca;
    • Devine, Karen;
    • Ahmad, Shazaad;
    • Huq, Raqib;
    • Marshall, Suzanne;
    • McLaughlan, Danielle;
    • Lavery, Mark;
    • Challenger, Elizabeth;
    • Else, Laura J;
    • Semple, Malcolm G;
    • Kaye, Stephen;
    • Khoo, Saye H;
    • Beadsworth, Michael B J;
    • Investigator, Airborne HCID Network and ISARIC4C
    Publication type:
    Article
    34

    Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2334, doi. 10.1093/jac/dkae232
    By:
    • Kiiza, Daniel;
    • Rostami-Hochaghan, Danial;
    • Alhassan, Yussif;
    • Seden, Kay;
    • Reynolds, Helen;
    • Kaboggoza, Julian P;
    • Taegtmeyer, Miriam;
    • Chen, Tao;
    • Challenger, Elizabeth;
    • Malaba, Thokozile;
    • Wang, Duolao;
    • Else, Laura;
    • Hern, Faye;
    • Sharp, Jo;
    • Neary, Megan;
    • Penchala, Sujan Dilly;
    • Waitt, Catriona;
    • Orrell, Catherine;
    • Colbers, Angela;
    • Myer, Landon
    Publication type:
    Article
    35

    Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 7, p. 1597, doi. 10.1093/jac/dkae147
    By:
    • Else, Laura J;
    • Dickinson, Laura;
    • Edick, Stacey;
    • Zyhowski, Ashley;
    • Ho, Ken;
    • Meyn, Leslie;
    • Dilly-Penchala, Sujan;
    • Thompson, Beth;
    • Shaw, Victoria;
    • Khoo, Saye;
    • Brand, Rhonda M
    Publication type:
    Article
    36
    37
    38
    39
    40

    Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1415475
    By:
    • Webb, Emily L.;
    • Petkov, Stefan;
    • Yun, Heejin;
    • Else, Laura;
    • Lebina, Limakatso;
    • Serwanga, Jennifer;
    • Pillay, Azure-Dee A. P.;
    • Seiphetlo, Thabiso B.;
    • Mugaba, Susan;
    • Namubiru, Patricia;
    • Odoch, Geoffrey;
    • Opoka, Daniel;
    • Ssemata, Andrew S.;
    • Kaleebu, Pontiano;
    • Khoo, Saye;
    • Martinson, Neil;
    • Fox, Julie;
    • Gray, Clive M.;
    • Herrera, Carolina;
    • Chiodi, Francesca
    Publication type:
    Article
    41

    Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1415475
    By:
    • Webb, Emily L.;
    • Petkov, Stefan;
    • Yun, Heejin;
    • Else, Laura;
    • Lebina, Limakatso;
    • Serwanga, Jennifer;
    • Pillay, Azure-Dee A. P.;
    • Seiphetlo, Thabiso B.;
    • Mugaba, Susan;
    • Namubiru, Patricia;
    • Odoch, Geoffrey;
    • Opoka, Daniel;
    • Ssemata, Andrew S.;
    • Kaleebu, Pontiano;
    • Khoo, Saye;
    • Martinson, Neil;
    • Fox, Julie;
    • Gray, Clive M.;
    • Herrera, Carolina;
    • Chiodi, Francesca
    Publication type:
    Article
    42
    43

    Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

    Published in:
    Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e525, doi. 10.1093/cid/ciac199
    By:
    • FitzGerald, Richard;
    • Dickinson, Laura;
    • Else, Laura;
    • Fletcher, Thomas;
    • Hale, Colin;
    • Amara, Alieu;
    • Walker, Lauren;
    • Penchala, Sujan Dilly;
    • Lyon, Rebecca;
    • Shaw, Victoria;
    • Greenhalf, William;
    • Bullock, Katie;
    • Lavelle-Langham, Lara;
    • Reynolds, Helen;
    • Painter, Wendy;
    • Holman, Wayne;
    • Ewings, Sean;
    • Griffiths, Gareth;
    • Khoo, Saye
    Publication type:
    Article
    44

    Total and Unbound Doravirine Concentrations and Viral Suppression in CSF.

    Published in:
    Clinical Infectious Diseases, 2022, v. 74, n. 10, p. 1855, doi. 10.1093/cid/ciab835
    By:
    • Tiraboschi, Juan;
    • Scévola, Sofia;
    • Penchala, Sujan Dilly;
    • Challenger, Elisabeth;
    • Else, Laura;
    • Prieto, Paula;
    • Saumoy, Maria;
    • Imaz, Arkaitz;
    • Silva-Klug, Ana;
    • Niubó, Jordi;
    • Soriano, Irene;
    • Khoo, Saye;
    • Rigo-Bonin, Raul;
    • Podzamczer, Daniel
    Publication type:
    Article
    45
    46

    Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.

    Published in:
    Clinical Infectious Diseases, 2021, v. 73, n. 5, p. e1200, doi. 10.1093/cid/ciaa1861
    By:
    • Dickinson, Laura;
    • Walimbwa, Stephen;
    • Singh, Yashna;
    • Kaboggoza, Julian;
    • Kintu, Kenneth;
    • Sihlangu, Mary;
    • Coombs, Julie-Anne;
    • Malaba, Thokozile R;
    • Byamugisha, Josaphat;
    • Pertinez, Henry;
    • Amara, Alieu;
    • Gini, Joshua;
    • Else, Laura;
    • Heiberg, Christie;
    • Hodel, Eva Maria;
    • Reynolds, Helen;
    • Myer, Landon;
    • Waitt, Catriona;
    • Khoo, Saye;
    • Lamorde, Mohammed
    Publication type:
    Article
    47
    48
    49
    50

    An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 585, doi. 10.1002/cpt.2463
    By:
    • Walker, Lauren E.;
    • FitzGerald, Richard;
    • Saunders, Geoffrey;
    • Lyon, Rebecca;
    • Fisher, Michael;
    • Martin, Karen;
    • Eberhart, Izabela;
    • Woods, Christie;
    • Ewings, Sean;
    • Hale, Colin;
    • Rajoli, Rajith K. R.;
    • Else, Laura;
    • Dilly‐Penchala, Sujan;
    • Amara, Alieu;
    • Lalloo, David G.;
    • Jacobs, Michael;
    • Pertinez, Henry;
    • Hatchard, Parys;
    • Waugh, Robert;
    • Lawrence, Megan
    Publication type:
    Article